Literature DB >> 33723367

Type 2 diabetes progression differently affects endothelial function and vascular contractility in the aorta and the pulmonary artery.

Bernardete F Melo1, Jesus Prieto-Lloret1, Marlene D Cabral1, Fatima O Martins1, Inês B Martins1, Joana F Sacramento1, Pedro Ruivo2, Tânia Carvalho2,3, Silvia V Conde4.   

Abstract

Type 2 diabetes (T2D) is associated with cardiovascular and pulmonary disease. How T2D affects pulmonary endothelial function is not well characterized. We investigated the effects of T2D progression on contractility machinery and endothelial function in the pulmonary and systemic circulation and the mechanisms promoting the dysfunction, using pulmonary artery (PA) and aorta. A high-fat (HF, 3 weeks 60% lipid-rich diet) and a high-fat/high-sucrose (HFHSu, combined 60% lipid-rich diet and 35% sucrose during 25 weeks) groups were used as prediabetes and T2D rat models. We found that T2D progression differently affects endothelial function and vascular contractility in the aorta and PA, with the contractile machinery being altered in the PA and aorta in prediabetes and T2D animals; and endothelial function being affected in both models in the aorta but only affected in the PA of T2D animals, meaning that PA is more resistant than aorta to endothelial dysfunction. Additionally, PA and systemic endothelial dysfunction in diabetic rats were associated with alterations in the nitrergic system and inflammatory pathways. PA dysfunction in T2D involves endothelial wall mineralization. The understanding of the mechanisms behind PA dysfunction in T2D can lead to significant advances in both preventative and therapeutic treatments of pulmonary disease-associated diabetes.

Entities:  

Year:  2021        PMID: 33723367     DOI: 10.1038/s41598-021-85606-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

Authors:  Kathryn C B Tan; Wing-Sun Chow; Victor H G Ai; Christine Metz; Richard Bucala; Karen S L Lam
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

Review 2.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

Review 3.  Vascular nitric oxide: Beyond eNOS.

Authors:  Yingzi Zhao; Paul M Vanhoutte; Susan W S Leung
Journal:  J Pharmacol Sci       Date:  2015-09-28       Impact factor: 3.337

Review 4.  Endothelial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  R Dhananjayan; K S Srivani Koundinya; T Malati; Vijay Kumar Kutala
Journal:  Indian J Clin Biochem       Date:  2015-09-29

5.  NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.

Authors:  Ines Nevelsteen; An Van den Bergh; Gerry Van der Mieren; Annelies Vanderper; Kanigula Mubagwa; Hidde Bult; Paul Herijgers
Journal:  J Vasc Res       Date:  2013-10-31       Impact factor: 1.934

6.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

Authors:  S D Yan; A M Schmidt; G M Anderson; J Zhang; J Brett; Y S Zou; D Pinsky; D Stern
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

Review 7.  Vascular endothelial dysfunction and pharmacological treatment.

Authors:  Jin Bo Su
Journal:  World J Cardiol       Date:  2015-11-26

Review 8.  A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus.

Authors:  Giuseppe Derosa; Pamela Maffioli
Journal:  Vasc Health Risk Manag       Date:  2016-11-09

9.  Interaction of IL-6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts.

Authors:  Jonghae Lee; Sewon Lee; Hanrui Zhang; Michael A Hill; Cuihua Zhang; Yoonjung Park
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 10.  Insulin resistance: vascular function and exercise.

Authors:  Moon-Hyon Hwang; Sewon Lee
Journal:  Integr Med Res       Date:  2016-06-09
View more
  1 in total

1.  Therapeutic Benefits of Pomegranate Flower Extract: A Novel Effect That Reduces Oxidative Stress and Significantly Improves Diastolic Relaxation in Hyperglycemic In Vitro in Rats.

Authors:  Yuanyuan Wei; Ahmad Taha Khalaf; Peng Ye; Wei Fan; Junyi Su; Wanlu Chen; Hao Hu; Rashid Menhas; Lifeng Wang; Zahraa Oglah
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.